CONTEXT: Advances in antiretroviral therapy (ART) for HIV offer life-extending benefit; however, the side effects associated with ART use negatively impact quality of life and medication adherence among people living with HIV. OBJECTIVES: This study tested the efficacy of Mindfulness-Based Stress Reduction (MBSR) for reducing ART symptoms and bother/distress related to ART side effects. Secondary aims were to test the impact of MBSR on medication adherence and psychological functioning. METHODS:Seventy-six people living with HIV who were actively taking ART and reported distress from ART-related side effects were randomly assigned to an MBSR program or a wait-list control (WLC) standard care condition. We measured side effects, ART adherence, perceived stress, depression, positive and negative affect, and mindfulness at three time points: baseline, three-month follow-up, and six-month follow-up. Side effects and related distress were assessed separately from other symptoms. RESULTS: Compared with a WLC, participants in the MBSR condition experienced a reduction in the frequency of symptoms attributable to ARTs at three months post-intervention (mean difference=0.33; 95% confidence interval [CI]=0.01, 0.66; t(132)=2.04, P=0.044) and six months post-intervention (mean difference=0.38; 95% CI=0.05, 0.71; t(132)=2.27, P=0.025). MBSR participants also experienced a reduction in distress associated with those symptoms at three months post-intervention (mean difference=0.47; 95% CI=0.003, 0.94; t(132)=1.99, P=0.048) compared with the WLC condition. CONCLUSION:MBSR is a promising approach for reducing HIV treatment-related side effects.
RCT Entities:
CONTEXT: Advances in antiretroviral therapy (ART) for HIV offer life-extending benefit; however, the side effects associated with ART use negatively impact quality of life and medication adherence among people living with HIV. OBJECTIVES: This study tested the efficacy of Mindfulness-Based Stress Reduction (MBSR) for reducing ART symptoms and bother/distress related to ART side effects. Secondary aims were to test the impact of MBSR on medication adherence and psychological functioning. METHODS: Seventy-six people living with HIV who were actively taking ART and reported distress from ART-related side effects were randomly assigned to an MBSR program or a wait-list control (WLC) standard care condition. We measured side effects, ART adherence, perceived stress, depression, positive and negative affect, and mindfulness at three time points: baseline, three-month follow-up, and six-month follow-up. Side effects and related distress were assessed separately from other symptoms. RESULTS: Compared with a WLC, participants in the MBSR condition experienced a reduction in the frequency of symptoms attributable to ARTs at three months post-intervention (mean difference=0.33; 95% confidence interval [CI]=0.01, 0.66; t(132)=2.04, P=0.044) and six months post-intervention (mean difference=0.38; 95% CI=0.05, 0.71; t(132)=2.27, P=0.025). MBSR participants also experienced a reduction in distress associated with those symptoms at three months post-intervention (mean difference=0.47; 95% CI=0.003, 0.94; t(132)=1.99, P=0.048) compared with the WLC condition. CONCLUSION: MBSR is a promising approach for reducing HIV treatment-related side effects.
Authors: John Christopher Walsh; Anton Louis Pozniak; Mark Richard Nelson; Sundhiya Mandalia; Brian George Gazzard Journal: J Acquir Immune Defic Syndr Date: 2002-07-01 Impact factor: 3.731
Authors: Mallory O Johnson; Margaret A Chesney; Torsten B Neilands; Samantha E Dilworth; Robert H Remien; Lance S Weinhardt; F Lennie Wong; Stephen F Morin Journal: J Gen Intern Med Date: 2008-11-18 Impact factor: 5.128
Authors: Frederick M Hecht; Judith T Moskowitz; Patricia Moran; Elissa S Epel; Peter Bacchetti; Michael Acree; Margaret E Kemeny; Wendy Berry Mendes; Larissa G Duncan; Helen Weng; Jay A Levy; Steven G Deeks; Susan Folkman Journal: Brain Behav Immun Date: 2018-05-26 Impact factor: 7.217
Authors: Lawrence Mbuagbaw; Bhairavi Sivaramalingam; Tamara Navarro; Nicholas Hobson; Arun Keepanasseril; Nancy J Wilczynski; R Brian Haynes Journal: AIDS Patient Care STDS Date: 2015-03-31 Impact factor: 5.078
Authors: Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell Journal: AIDS Behav Date: 2014-04
Authors: Mary Catherine George; Arada Wongmek; Michelle Kaku; Alexandra Nmashie; Jessica Robinson-Papp Journal: Behav Med Date: 2015-12-11 Impact factor: 3.104